CPhI: Saltigo Develops Generic Pharmaceuticals Strategy

Saltigo, the custom synthesis and manufacturing services subsidiary of Lanxess, says the business is trying to develop strategies for manufacturing generic drugs for its pharma customers. Additionally, the business says that in future there will be more alliances between pharmaceutical contract manufacturers. “Custom manufacturing companies with different expertise such as those with expertise in technology and with lower cost platforms will form more alliances in the future,” Andreas Stolle, head of the pharma business line pharma at Saltigo, tells...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers